Viral Logic Systems Technology (VLST)
The process used to identify targets also provides a clear path to developing biologic molecules that can be used for target validation studies. The VLST approach reduces the time to clinical development and improves the likelihood of clinical success. The company is headquartered in Seattle, Washington. Gerry Langeler is on the board.
Page 5 of 5